Tyler Brous

Tyler Brous is currently a board member at ColdQuanta. Tyler has also previously served as a board member at CerSci Therapeutics Inc from January 2018 to August 2020. In this role, they helped the company get acquired by Acadia Pharmaceuticals for $52.5 million in Acadia stock and up to $887 million in development, commercialization and sales milestones. Prior to that, they were an analyst at YX Funds from January 2007 to December 2011 and an investment banking analyst - M&A at Citi from January 2005 to December 2007.

Tyler Brous completed a Bachelor of Business Administration (BBA) at The University of Texas at Austin, with a focus in Business Honors & Finance.